We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

194 hedge funds and large institutions have $1.49B invested in Enanta Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 77 increasing their positions, 55 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 55

8% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 26

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1% less funds holding

Funds holding: 195 → 194 (-1)

1.87% less ownership

Funds ownership: 91.61% → 89.73% (-1.9%)

12% less capital invested

Capital invested by funds: $1.7B → $1.49B (-$212M)

63% less call options, than puts

Call options by funds: $4.51M | Put options by funds: $12.2M

Holders
194
Holders Change
-1
Holders Change %
-0.51%
% of All Funds
4.21%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
28
Increased
77
Reduced
55
Closed
26
Calls
$4.51M
Puts
$12.2M
Net Calls
-$7.66M
Net Calls Change
-$5.29M

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$17.8M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$14.3M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$6.33M
4
Ameriprise
Ameriprise
Minnesota
+$6.12M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$5.99M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$22.3M
2
MWNA
Marshall Wace North America
New York
-$15.3M
3
Invesco
Invesco
Georgia
-$9.23M
4
Renaissance Technologies
Renaissance Technologies
New York
-$8.56M
5
Millennium Management
Millennium Management
New York
-$8.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
TD Asset Management
51
TD Asset Management
Ontario, Canada
$3.25M +$306K +3,400 +10%
Mackenzie Financial
52
Mackenzie Financial
Ontario, Canada
$3.19M +$3.13M +34,843 +1,197%
Barclays
53
Barclays
United Kingdom
$3.09M -$1.76M -19,584 -35%
Public Sector Pension Investment Board (PSP Investments)
54
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.97M +$1.86M +20,700 +143%
Rafferty Asset Management
55
Rafferty Asset Management
New York
$2.94M +$22.5K +250 +0.7%
Baird Financial Group
56
Baird Financial Group
Wisconsin
$2.89M +$3.08M +34,290 New
New York State Common Retirement Fund
57
New York State Common Retirement Fund
New York
$2.88M -$27K -300 -0.9%
Prudential Financial
58
Prudential Financial
New Jersey
$2.84M +$58.5K +650 +2%
GAM
59
Gotham Asset Management
New York
$2.73M +$1.23M +13,693 +73%
PPA
60
Parametric Portfolio Associates
Washington
$2.49M -$224K -2,489 -8%
Wells Fargo
61
Wells Fargo
California
$2.43M +$150K +1,668 +6%
Two Sigma Advisers
62
Two Sigma Advisers
New York
$2.38M +$1.58M +17,600 +166%
Citigroup
63
Citigroup
New York
$2.37M +$1.35M +14,959 +115%
Swiss National Bank
64
Swiss National Bank
Switzerland
$2.29M +$54K +600 +2%
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
$2.23M +$69.2K +769 +3%
MSE
66
MUFG Securities EMEA
United Kingdom
$2.23M +$2.37M +26,400 New
ASRS
67
Arizona State Retirement System
Arizona
$2.08M +$38K +422 +2%
State of Wisconsin Investment Board
68
State of Wisconsin Investment Board
Wisconsin
$2.06M +$171K +1,900 +8%
California Public Employees Retirement System
69
California Public Employees Retirement System
California
$2.04M -$936K -10,405 -30%
Skandinaviska Enskilda Banken (SEB)
70
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.02M -$531K -5,900 -20%
CS
71
Credit Suisse
Switzerland
$1.91M +$102K +1,132 +5%
KBC Group
72
KBC Group
Belgium
$1.85M -$121K -1,350 -6%
Canada Life
73
Canada Life
Manitoba, Canada
$1.77M +$11.2K +124 +0.6%
SEI Investments
74
SEI Investments
Pennsylvania
$1.74M – – –
KC
75
Kepos Capital
New York
$1.69M – – –
1 2
3
4 5

ENTA Hedge Fund Activity: Q2 2019 in Review

194 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q2 2019, worth a combined $1.49B — down 12% from $1.7B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ENTA positions and 26 closed out — a net gain of 2 holders — while 77 added to existing stakes and 55 trimmed.

The largest buyer was Nuveen, opening a new position worth an estimated $17.8M. The largest seller was OrbiMed, exiting entirely with an estimated $22.3M sold.

  • 194 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q2 2019, down from 195 in Q1 2019.
  • Funds reported $1.49B of Enanta Pharmaceuticals stock for Q2 2019, down 12% quarter-over-quarter.
  • 28 funds opened new Enanta Pharmaceuticals positions in Q2 2019 and 26 closed out, a net change of +2 holders.
  • The largest Enanta Pharmaceuticals buyer in Q2 2019 was Nuveen, an estimated $17.8M added.
  • The largest Enanta Pharmaceuticals seller in Q2 2019 was OrbiMed, an estimated $22.3M sold.

Based on aggregated 13F filings for Q2 2019.